vTv Therapeutics (VTVT) Other Non-Current Liabilities (2014 - 2022)

vTv Therapeutics (VTVT) has 9 years of Other Non-Current Liabilities data on file, last reported at $770000.0 in Q1 2022.

• For the quarter ending Q1 2022, Other Non-Current Liabilities rose 1440.0% year-over-year to $770000.0; the trailing twelve-month figure through Mar 2022 stood at $770000.0 (up 1440.0% YoY), and the FY2021 full-year result was $1.3 million, up 2424.0% from the prior year.
• Other Non-Current Liabilities declined to $770000.0 in Q1 2022, from $1.3 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.3 million in Q4 2021 to a low of $50000.0 in Q4 2020.
• A 5-year average of $276294.1 and a median of $258000.0 in 2018 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities plunged 80.77% in 2020 and jumped 2424.0% in 2021, its largest moves.
• Tracing VTVT's Other Non-Current Liabilities over 5 years: stood at $260000.0 in 2018, then changed by 0.0% to $260000.0 in 2019, then sank by 80.77% to $50000.0 in 2020, then jumped by 2424.0% to $1.3 million in 2021, then plunged by 38.99% to $770000.0 in 2022.
• Business Quant data shows VTVT's Other Non-Current Liabilities at $770000.0 in Q1 2022, $1.3 million in Q4 2021, and $50000.0 in Q3 2021.